This study aims to address this gap by providing a comprehensive analysis of CD68+ and CD163+ macrophages in cutaneous melanoma stages I–III, which may be critical for elucidating the mechanisms of tumor progression. This evidence concerns the gene CD163 and cutaneous melanoma.